ArticleHemaSphere2026

Quality of life with nivolumab and AVD first-line treatment of Hodgkin lymphoma in the Phase II GHSG NIVAHL trial.

Christian Peter Jaworek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.